News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
370,574 Results
Type
Article (15970)
Company Profile (118)
Press Release (354486)
Section
Business (114643)
Career Advice (521)
Deals (19015)
Drug Delivery (37)
Drug Development (32141)
Employer Resources (59)
FDA (8970)
Job Trends (7956)
News (176358)
Policy (12888)
Tag
Academia (1398)
Alliances (35137)
Alzheimer's disease (512)
Approvals (8972)
Artificial intelligence (199)
Bankruptcy (135)
Best Places to Work (6737)
Biotechnology (89)
Breast cancer (99)
Cancer (838)
Career advice (455)
CAR-T (83)
Cell therapy (238)
Clinical research (24948)
Collaboration (493)
Compensation (89)
COVID-19 (1176)
C-suite (101)
Data (783)
Diabetes (80)
Diagnostics (4925)
Earnings (38674)
Events (52059)
Executive appointments (322)
FDA (9443)
Funding (410)
Gene editing (75)
Gene therapy (166)
GLP-1 (232)
Government (1377)
Healthcare (10384)
Infectious disease (1238)
IPO (8181)
Job creations (1507)
Job search strategy (402)
Layoffs (126)
Legal (2638)
Lung cancer (107)
Manufacturing (153)
Medical device (11474)
Medtech (11479)
Mergers & acquisitions (11089)
Metabolic disorders (184)
Neuroscience (674)
NextGen: Class of 2025 (3725)
Non-profit (1728)
Northern California (945)
Obesity (82)
Opinion (87)
Patents (99)
People (33364)
Phase I (9235)
Phase II (11242)
Phase III (7402)
Pipeline (330)
Postmarket research (526)
Preclinical (4108)
Press Release (66)
Radiopharmaceuticals (156)
Rare diseases (142)
Real estate (3421)
Regulatory (9530)
Research institute (1326)
Resumes & cover letters (82)
Series A (75)
Southern California (974)
Startups (2567)
United States (9618)
Vaccines (292)
Date
Today (3)
Last 7 days (313)
Last 30 days (1319)
Last 365 days (18516)
2025 (2426)
2024 (19052)
2023 (22518)
2022 (31326)
2021 (33098)
2020 (31289)
2019 (26869)
2018 (20161)
2017 (19302)
2016 (18226)
2015 (21083)
2014 (15505)
2013 (12998)
2012 (14053)
2011 (14347)
2010 (13027)
Location
Africa (327)
Arizona (110)
Asia (24144)
Australia (4228)
California (2400)
Canada (919)
China (192)
Colorado (140)
Connecticut (114)
Europe (49724)
Florida (375)
Georgia (114)
Illinois (257)
Indiana (133)
Japan (83)
Kansas (78)
Maryland (393)
Massachusetts (1657)
Michigan (171)
Minnesota (217)
New Jersey (735)
New York (694)
North Carolina (466)
Northern California (945)
Ohio (94)
Pennsylvania (490)
South America (530)
Southern California (974)
Texas (374)
Utah (85)
Washington State (285)
370,574 Results for "blue spark technologies".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
SHINE Technologies Partners with Blue Earth Therapeutics for First Supply of Ilumira from Its New Facility
SHINE Technologies, LLC (SHINE), a pioneer in next-generation fusion-based technology, today announced a new partnership with Blue Earth Therapeutics, a Bracco company and recognized leader in the development of innovative radiopharmaceuticals.
June 6, 2024
·
3 min read
BioMidwest
Blue Spark Technologies to Highlight Continuous Patient Temperature Monitoring at CES 2023
Blue Spark Technologies, Inc., a leader in wearable remote patient monitoring solutions, will showcase TempTraq® at the 2023 Consumer Electronics Show at the Las Vegas Convention Center January 5-8.
January 3, 2023
·
3 min read
Mergers & acquisitions
Biopharma Heads to JP Morgan Seeking an M&A Spark to Improve Sentiment
M&A didn’t return as hoped for in 2024. The biopharma industry is heading into the J.P. Morgan Healthcare Conference next week in a grim mood.
January 6, 2025
·
5 min read
·
Annalee Armstrong
FDA
Blue Arbor Technologies Receives FDA Breakthrough Device Designation and TAP Enrollment for the RESTORE™ Neuromuscular Interface System
Blue Arbor Technologies Inc. announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to the RESTORE™ Neuromuscular Interface System for people with upper limb loss.
April 24, 2024
·
6 min read
BioMidwest
NeurAxis Announces Blue Cross and Blue Shield of Kansas City Policy Coverage
NeurAxis, Inc., a medical technology company commercializing neuromodulation therapies addressing chronic and debilitating conditions in children and adults, announced receipt of Blue Cross and Blue Shield of Kansas City policy coverage for approximately one million lives.
March 4, 2024
·
3 min read
Business
Longtime Mayo Clinic Neurologist Dr. Richard J. Caselli Joins SPARK Neuro as Medical Director
SPARK Neuro, a leader in brain health diagnostics, announces the appointment of Dr. Richard J. Caselli as its Medical Director.
April 16, 2024
·
2 min read
Business
Blue Spark Technologies Announces Appointment of John DeFord, Ph.D. to its Board of Directors
Blue Spark Technologies Inc. announced today the appointment of John DeFord, Ph.D. to its board of directors.
May 2, 2022
·
2 min read
Business
Spectral AI Appoints Jeremiah Sparks as Chief Commercialization Officer
Spectral AI, Inc. today announced the appointment of Jeremiah A. Sparks as Chief Commercialization Officer. Jeremiah has more than 20 years of medical device marketing experience, including global marketing and business strategy.
April 1, 2024
·
4 min read
Pharm Country
Blue Earth Diagnostics Highlights Presentations on POSLUMA®
Blue Earth Diagnostics Highlights Presentations on POSLUMA® at Upcoming Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting to be held June 8 to 11, 2024, in Toronto, Canada.
May 29, 2024
·
10 min read
Press Releases
Nexus Pharmaceuticals Receives FDA Approval for Methylene Blue Injection, USP
November 26, 2024
·
1 min read
1 of 37,058
Next
